GovChime
Notice ID: 5bdd0ce9e9f34d9f911b37c1f9e94bc0Solicitation

Ondansetron Orally Disintegrating Tablets

Responses closed . Full description on SAM.gov.

Overview

Response deadline
3:00 PM EDT
Posted
April 8, 2026
Notice type
Solicitation
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
SPE2D2-25-R-0018
Notice ID
5bdd0ce9e9f34d9f911b37c1f9e94bc0

Description

Amendment 0004 issued since this procurement is using the procedures of 41 U.S.C. 1901, as implemented by Class Deviation 2026-O0028 – Revolutionary Federal Acquisition Regulation (FAR) Overhaul Part 12, Defense FAR Supplement (DFARS) Part 212 and Revolutionary FAR Overhaul Part 12.201-1. See updated Ondansetron ODT Solicitation attached. 

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (6)

  • Updated Ondansetron Solicitation - FAR Overhaul - 08.Apr.2026.pdf

    1.4 MBAdded in Solicitation version 6Posted
    Download
  • Amendment 0003 - Ondansetron ODT.pdf

    107 KBAdded in Solicitation version 5Posted
    Download
  • Amendment 0002 - Ondansetron ODT.pdf

    11 KBAdded in Solicitation version 4Posted
    Download
  • Schedule of Supplies - Ondansetron - Revised.pdf

    118 KBAdded in Solicitation version 3Posted
    Download
  • Amendment 0001 - Ondansetron ODT.pdf

    12 KBAdded in Solicitation version 3Posted
    Download
  • Ondansetron ODT Solicitation - SPE2D2-25-R-0018.pdf

    1.3 MBAdded in Solicitation version 2Posted
    Download

Lifecycle

  1. 1
    Version 1Presolicitation

    Ondansetron Orally Disintegrating Tablets

    Notice 44e2d74f5e1341d4a4a0d45efbb3a79d on SAM.gov

  2. 2
    Version 2Solicitation

    Type changed from Presolicitation to Solicitation

    Ondansetron Orally Disintegrating Tablets

    Notice 29e3d7e197744ebf930571a25f98cae1 on SAM.gov

  3. 3
    Version 3Solicitation

    Ondansetron Orally Disintegrating Tablets

    Notice c175e690919c4f92b0e8bf2e328dda62 on SAM.gov

  4. 4
    Version 4Solicitation

    Ondansetron Orally Disintegrating Tablets

    Notice 31f37057303448d4831a7ed04fcd4412 on SAM.gov

  5. 5
    Version 5Solicitation

    Ondansetron Orally Disintegrating Tablets

    Notice ba075f8cd26d479abd41d6f880519b1d on SAM.gov

  6. 6
    Version 6SolicitationCurrent

    Ondansetron Orally Disintegrating Tablets

    Notice 5bdd0ce9e9f34d9f911b37c1f9e94bc0 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

SPE2D2-25-R-0018

Archive Date

Mar 30, 2027

Office Address

PHILADELPHIA, PA, 19111